Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Exercise testing identifies high-risk silent ischaemia

This article was originally published in Clinica

Executive Summary

A Finnish study has highlighted the importance of exercise testing as a means of predicting coronary heart disease (CHD) I asymptomatic, high-risk men. In men with increased risk of CHD, such as smokers and hypercholesterolaemic or hypertensive men, the identification of exercise-induced silent myocardial ischaemia is of significant additional prognostic value, researchers report in the Journal of the American College of Cardiology (July).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT072071

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel